Beam Therapeutics Inc (NAS:BEAM)
$ 21.26 -1.28 (-5.68%) Market Cap: 1.75 Bil Enterprise Value: 823.50 Mil PE Ratio: 0 PB Ratio: 1.91 GF Score: 39/100

Beam Therapeutics Inc at RBC Capital Markets Global Healthcare Conference Transcript

May 17, 2023 / 03:00PM GMT
Release Date Price: $34.96 (+3.25%)
Luca Issi
RBC Capital Markets, LLC - Moderator

Hello, great, thanks. Hello, everybody. Luca Issi, Senior Biotech Analyst here at RBC Capital Market, and today is our great privilege to have Beam Therapeutics with us for a fireside chat.

Representing the company, we have use Giuseppe Ciaramella, President of the organization. Giuseppe, thanks so much for joining us. How are you doing today?

Giuseppe Ciaramella
Beam Therapeutics Inc. - President

Doing very well, and thanks for the invitation, and the opportunity to share some of the updates with you.

Questions & Answers

Luca Issi;Giuseppe Ciaramella
RBC Capital Markets, LLC - Moderator;Beam

Great, very great. So we have a long list of questions here, but maybe before we talk about the individual program, Giuseppe, it will be fantastic if you can just give us a little bit of a big picture overview of what progress has the organization made over the last few months. And most importantly, what's ahead here for Beam?

Already have an account? Log in
Get the full story
Access to All Earning Calls and Stock Analysis
30-Year Financial on one screen
All-in-one Stock Screener with unlimited filters
Customizable Stock Dashboard
Real Time Insider Trading Transactions
8,000+ Institutional investors’ 13F holdings
Powerful Excel Add-in and Google sheets Add-on
All data downloadable
Quick customer support
And much more...
30-Day 100% money back guarantee
You are not charged until the trial ends. Subscription fee may be tax deductible.
Excellent
4.6 out of 5 Trustpilot